EquityZen Growth Technology Fund LLC - Series 1883
Raised
$265K
Investors
19
Min Invest
$5,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1883 is a Delaware limited liability company filing under Rule 506(b) and 3(c)(1), raising $265K from 19 investors with a $5K minimum investment. Filed May 2024 by EquityZen Advisors LLC and Phil Haslett, this is one of approximately 1,889 related entities on the EquityZen pre-IPO investment platform.
This pre-IPO pooled investment vehicle follows the standard EquityZen series structure with a retail-accessible $5K minimum entry point and 506(b) private placement exemption limiting general solicitation. The 19-investor count and $265K raise ($13.9K average ticket) is consistent with EquityZen's fractional secondary share model for emerging growth companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.